Efficacy of Dual-Hormone Artificial Pancreas to Alleviate the Carbohydrate Counting Burden in Type 1 Diabetes: Randomized Crossover Trial

2014 ◽  
Vol 38 (5) ◽  
pp. S12-S13
Author(s):  
Véronique Gingras ◽  
Rémi Rabasa-Lhoret ◽  
Virginie Messier ◽  
Melika Forde ◽  
Laurent Legault ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Crossover Trial ◽  
Artificial Pancreas ◽  
Carbohydrate Counting ◽  
Randomized Crossover Trial

19 - A Fully-Automated Artificial Pancreas to Alleviate the Burden of Carbohydrate Counting in Type 1 Diabetes

2019 ◽  
Vol 43 (7) ◽  
pp. S8
Author(s):  
Dorsa Majdpour ◽  
Michael Tsoukas ◽  
Jean-Francois Yale ◽  
Ahmad Haidar
Keyword(s):  
Type 1 Diabetes ◽  
Artificial Pancreas ◽  
Carbohydrate Counting

scholarly journals Reduction in insulin degludec dosing for multiple exercise sessions improves time spent in euglycaemia in people with type 1 diabetes: A randomized crossover trial

2018 ◽  
Vol 21 (2) ◽  
pp. 349-356 ◽  
Author(s):  
Othmar Moser ◽  
Max L. Eckstein ◽  
Alexander Mueller ◽  
Philipp Birnbaumer ◽  
Felix Aberer ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Crossover Trial ◽  
Insulin Degludec ◽  
Randomized Crossover Trial

scholarly journals Home Use of Day-and-Night Hybrid Closed-Loop Insulin Delivery in Suboptimally Controlled Adolescents With Type 1 Diabetes: A 3-Week, Free-Living, Randomized Crossover Trial

Diabetes Care ◽  
2016 ◽  
Vol 39 (11) ◽  
pp. 2019-2025 ◽  
Author(s):  
Martin Tauschmann ◽  
Janet M. Allen ◽  
Malgorzata E. Wilinska ◽  
Hood Thabit ◽  
Carlo L. Acerini ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Closed Loop ◽  
Crossover Trial ◽  
Insulin Delivery ◽  
Free Living ◽  
Randomized Crossover Trial
Sign in / Sign up

Export Citation Format

Share Document